Overview
- 18 inspections across 18 sites are on record.
- 16 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2015-03-27.
At a glance
Inspections
18
Sites
18
Observations
16
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Second Pharma Co., Ltd. | 27 Mar 2015 | Human Drugs | On file |
| Esteve Huayi Pharmaceutical Co., Ltd. | 20 Mar 2015 | Human Drugs | |
| Qingdao Jiulong Biopharmaceutical Co., Ltd. | 13 Mar 2015 | Human Drugs | |
| Hikal Limited | 11 Apr 2014 | Human Drugs | On file |
| Emcure Pharmaceuticals Limited | 4 Apr 2014 | Human Drugs | On file |
Sites inspected
Second Pharma Co., Ltd.Shaoxing, China1 insp.
Esteve Huayi Pharmaceutical Co., Ltd.Shaoxing, China1 insp.
Qingdao Jiulong Biopharmaceutical Co., Ltd.Qingdao, China1 insp.
Hikal LimitedJigani, India1 insp.
Emcure Pharmaceuticals LimitedPune, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Marijo B Kambere3 shared
Gayle S Lawson3 shared
Jose A Cruz Gonzalez3 shared
Debra M Emerson3 shared
Shirley J Berryman2 shared
Douglas C Kovacs2 shared
Randy D Moore1 shared
Farhana Khan1 shared
Full investigator report
Get the verbatim findings behind Neal L Adams' 16 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site